Resources from the same session
3745 - Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy
Presenter: Georgina Long
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
5845 - Intratumoral (IT) Injection of the TLR9 agonist tilsotolimod (IMO-2125) in combination with ipilimumab (ipi) triggers durable responses in PD-1 inhibitor refractory metastatic melanoma (rMM): Results from a Multicenter, Phase 1/2 study
Presenter: Adi Diab
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
2134 - Talimogene laherparepvec (T-VEC) treatment increases intratumoral effector T-cell and natural killer (NK) cell density in noninjected tumors in patients (pts) with stage IIIB–IVM1c melanoma: evidence for systemic effects in a phase 2, single-arm study
Presenter: Helen Gogas
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
4894 - Phase 2 Study Comparing Pembrolizumab (PEM) with Intermittent/short‐term dual MAPK pathway inhibition plus PEM in patients harboring the BRAFV600 mutation (IMPemBra).
Presenter: Elisa Rozeman
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
4311 - Initial results from a phase 3b/4 study evaluating two dosing regimens of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 511)
Presenter: Celeste Lebbé
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
3540 - Phase II multicenter, single arm, open label study of Nivolumab in combination with Ipilimumab in untreated patients with metastatic uveal melanoma. GEM1402.NCT02626962
Presenter: Josep Maria Piulats Rodriguez
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
Poster Discussion session - Melanoma and other skin tumours - Invited Discussant LBA47 and 1247PD
Presenter: Georgina Long
Session: Poster Discussion session - Melanoma and other skin tumours
5352 - Efficacy of Pembrolizumab (Pembro) in Patients (Pts) With Advanced Melanoma with Stable Brain Metastases (BM) at Baseline: A Pooled Retrospective Analysis
Presenter: Omid Hamid
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
1733 - Concomitant radiotherapy in melanoma brain metastases using the propensity score matching within the French cohort, MelBase.
Presenter: Clara Allayous
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Abstract
Poster Discussion session - Melanoma and other skin tumours - Invited Discussant 1248PD and 1249PD
Presenter: Jean Jacques Grob
Session: Poster Discussion session - Melanoma and other skin tumours
Resources:
Slides
Webcast